Inhibition of Protease-Resistant Prion Protein Accumulation In Vitro by Curcumin

AUTOR(ES)

Caughey, Byron

FONTE

American Society for Microbiology

RESUMO

Inhibition of the accumulation of protease-resistant prion protein (PrP-res) is a prime strategy in the development of potential transmissible spongiform encephalopathy (TSE) therapeutics. Here we show that curcumin (diferoylmethane), a major component of the spice turmeric, potently inhibits PrP-res accumulation in scrapie agent-infected neuroblastoma cells (50% inhibitory concentration, ∼10 nM) and partially inhibits the cell-free conversion of PrP to PrP-res. In vivo studies showed that dietary administration of curcumin had no significant effect on the onset of scrapie in hamsters. Nonetheless, other studies have shown that curcumin is nontoxic and can penetrate the brain, properties that give curcumin advantages over inhibitors previously identified as potential prophylactic and/or therapeutic anti-TSE compounds.

Documentos Relacionados

• Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines
• Glycosylation influences cross-species formation of protease-resistant prion protein
• Chaperone-supervised conversion of prion protein to its protease-resistant form
• Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms
• Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins.